|
Volumn 68, Issue 14, 2007, Pages 1163-
|
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes [7]
a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INTERFERON BETA SERINE;
PLACEBO;
BRAIN DAMAGE;
CLINICAL TRIAL;
DISEASE COURSE;
HUMAN;
LETTER;
MULTIPLE SCLEROSIS;
NEUROIMAGING;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OPTIC NEURITIS;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
BRAIN INJURIES;
DISEASE PROGRESSION;
HUMANS;
INTERFERON-BETA;
MULTIPLE SCLEROSIS;
|
EID: 34147154707
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000261131.23708.1c Document Type: Letter |
Times cited : (9)
|
References (0)
|